LIF

LIF

LIF 詳細

Molecule Name
Leukemia inhibitory factor
分子の別称
LIF,CDF,DIA,HILDA,MLPLI
Drug Development Progress
治験薬の数2
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
LIF Interleukin 6 Family Cytokine,D factor,Emfilermin,LIF,Differentiation-stimulating factor,LIF, Interleukin 6 Family Cytokine,Differentiation Inhibitory Activity,Cholinergic Differentiation Factor,Hepatocyte-Stimulating Factor III,Differentiation-Inducing Factor,Melanoma-Derived LPL Inhibitor,Human Interleukin In DA Cells,Leukemia Inhibitory Factor,HILDA,MLPLI,CDF,DIA
バックグランド
Leukemia inhibitory factor, or LIF, an interleukin 6 class cytokine, is a protein in cells that affects cell growth and development.Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Removal of LIF pushes stem cells toward differentiation, but they retain their proliferative potential or pluripotency. Therefore LIF is used in mouse embryonic stem cell culture. It is necessary to maintain the stem cells in an undifferentiated state, however genetic manipulation of embryonic stem cells allows for LIF independent growth, notably overexpression of the gene Nanog. LIF is not required for culture of human embryonic stem cells.

LIF 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
FalbikitugAZD-0171; MSC-1Phase 2 ClinicalAstrazeneca Plc
Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours
詳細
JAB-BX300JAB-BX300Phase 2 ClinicalJacobio Pharmaceuticals Co Ltd
Pancreatic Neoplasms; Solid tumours
詳細